Month: May 2020

A harmonization of ‘big data’ in examining long-term outcomes with contemporary treatment for pediatric and adult Hodgkin lymphoma patients is yielding a new approach to inform future clinical trial design and enhance clinical decision-making. Results are being shared as part of a poster presentation at the virtual American Society for Clinical Oncology Annual Meeting taking

Reviewed by Emily Henderson, B.Sc.May 29 2020 Scientific studies suggest that children with birth defects are at increased risk of cancer. However, it has not been assessed whether the type of cancer, the age at which they are diagnosed or the extent of cancer spread at the time of diagnosis, is different for children with

Reviewed by Emily Henderson, B.Sc.May 30 2020 Two University of Cincinnati students have developed an interactive dashboard that shows COVID-19 cases and deaths in Greater Cincinnati and other major U.S. cities. Known asthe COVID-19 Watcher, it joins a list of options available to the public to track the novel coronavirus. Benjamin Wissel, a student at

May 30 2020 Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, (hereinafter “Shinshu University”), have together developed a “tumor-tropic liposome technology” for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and

May 30 2020 The first global analysis of existing scientific studies related to COVID-19 and newborn babies highlights that it is uncommon for babies aged up to four weeks old to become infected with the virus, with recorded cases experiencing only mild symptoms and making a full recovery. From an analysis considering over 200 papers,

Reviewed by Emily Henderson, B.Sc.May 29 2020 Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present.

Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present. The test does not require the use

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) usually targets older adults and those with underlying medical conditions. Past evidence has shown that the prevalence of infection among children and teens is low. Now, new evidence has shown that children with coronavirus disease (COVID-19) experience a Kawasaki-like illness, called multisystem inflammatory syndrome in children (MIS-C).

Every major medical center in America sits on a gold mine. The data they hold about their patients and research participants could be worth millions of dollars to companies that would explore it for clues that could lead to new medicines, medical technologies, health apps, and more. Such efforts would take partnerships between industry and

Champale Greene-Anderson keeps the volume up on her television when she watches 5-year-old granddaughter Amor Robinson while the girl’s mom is at work. “So we won’t hear the gunshots,” Greene-Anderson said. “I have little bitty grandbabies, and I don’t want them to be afraid to be here.” As a preschooler, Amor already knows and fears

Reviewed by Emily Henderson, B.Sc.May 27 2020 A joint program of UT Southwestern Medical Center and Children’s Health has been approved as a Certified Duchenne Care Center (CDCC) by Parent Project Muscular Dystrophy (PPMD), the nation’s most comprehensive nonprofit organization focused on finding a cure for Duchenne muscular dystrophy. The UTSW/Children’s Health collaboration, which involves